You can learn more about our research and development through scientific publications and presentations from the Aeglea team and our collaborators.

Select a Program

June 2022

Health Care Resource Utilization in the Management of Patients with Arginase 1 Deficiency in the US: A Retrospective, Observational, Claims Database Study

April 2022

Pegzilarginase in Arginase 1 Deficiency: Results of the PEACE Pivotal Phase 3 Clinical Trial

March 2022

Pre-Analytical Considerations Are Important In The Pharmacological Assessment Of Enzyme Therapeutics

March 2022

Natural history of arginase 1 deficiency and the unmet needs of patients: A systematic review of case reports

March 2022

Arginase 1 Deficiency: Using Genetic Databases as a Tool to Establish Global Prevalence

December 2021

Treatment Outcomes with Pegzilarginase Compared with Standard of Care for Patients with Arginase 1 Deficiency

November 2021

Diagnosis of Arginase 1 Deficiency in a Patient With Cerebral Palsy

November 2021

Diagnosis and Long Term Treatment of Arginase 1 Deficiency

November 2021

Arginine: The Key Driver of Pathophysiology and Progression in Arginase 1 Deficiency

November 2021

Patient Characteristics in the Pivotal Phase 3 PEACE Trial of Pegzilarginase Human Enzyme Therapy for Arginase 1 Deficiency

Get In Touch With Us